C07K 14/1841
Hepatitis g
Official title: {Hepatitis G; Hepatitis NANBNCNDNE}
C07K14/1841 (Hepatitis g) appears on 2 US grants and 3 published applications in this corpus.
Search patents in C07K- Granted patents
- 2
- Published applications
- 3
- Assignees
- 3
- Inventors
- 4
- Latest grant
- 31 Jul 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
By publication year.
Recent patents
- Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein31 Jul 2018US 10,034,936 B2The United States of America as represented by the Secretary of the Department of Veterans Affairs
- Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies14 Oct 2014US 8,858,946 B2The United States of America as represented by the Secretary of the Department of Veterans Affairs
- Gb virus c (hepatitis g virus) for the treatment of hiv27 Nov 2014US 2014/0348866 A1The United States of America, as represented by the Secretary, Department of
- Gb virus c (hepatitis g virus) for the treatment of hiv8 Jan 2009US 2009/0010932 A1The United States of America as represented by the Secretary of the Department of Veterans Affairs
- GB virus C (hepatitis G virus) for the treatment of HIV2 Jun 2005US 2005/0118181 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.